NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical. (Nasdaq: SRTA, “Strata” or the “Company”), will release financial results for the second quarter ended June 30, 2026 on Tuesday, August 4, 2026 before the market opens. The company will hold a conference call on the same day at 8:00 am Eastern Time to discuss the results. The call will be hosted by Melissa Tomkiel, Strata’s Co-Chief Executive Officer and General Counsel, and Will Heyburn, Strata’s Co-Chief Executive Officer and Chief Financial Officer, and will include a question-and-answer session for call participants.
To join the live call, please register
here
. Upon registration, a dial-in and unique PIN will be provided to join the call.
An audio-only webcast of the call may be accessed from the Investors section of the Company’s website at
https://ir.stratacritical.com/
or by registering at the link
here
. A replay of the webcast will be available for one year.
About Strata Critical Medical, Inc.
Strata is a time-critical logistics and medical services provider to the U.S. healthcare industry. We operate one of the nation’s largest air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated “one call” solution for donor organ recovery.
Strata’s core services include air and ground logistics, surgical organ recovery, organ placement and normothermic regional perfusion for the transplant industry, as well as perfusion staffing and equipment solutions for cardiovascular surgery centers, offered under the Trinity Medical Solutions and Keystone Perfusion brands.
For more information, visit
www.srta.com
.
Contacts
Mathew Schneider
investors@srta.com
View the Zacks #1 Rank List
Strata Critical Medical to Report Second Quarter 2026 Financial Results on August 4, 2026
Strata Critical Medical will announce Q2 2026 financial results on August 4, followed by a conference call.
Quiver AI Summary
Strata Critical Medical (Nasdaq: SRTA) will announce its financial results for the second quarter ending June 30, 2026, on August 4, 2026, before the market opens and will host a conference call at 8:00 am Eastern Time to discuss these results. The call will be led by Co-CEOs Melissa Tomkiel and Will Heyburn and will include a Q&A session. Participants can register to join the call and will receive a dial-in number and PIN. An audio webcast will also be available on the company's website, with a replay accessible for one year. Strata Critical Medical specializes in time-critical logistics and medical services for the U.S. healthcare sector, providing a comprehensive range of services related to organ transport and surgical solutions.
Potential Positives
Potential Negatives
FAQ
When will Strata release its Q2 2026 financial results?
Strata will release its financial results for Q2 2026 on August 4, 2026, before the market opens.
What time is the Strata conference call?
The conference call will be held at 8:00 am Eastern Time on August 4, 2026.
Who will host the Strata conference call?
The call will be hosted by Melissa Tomkiel and Will Heyburn, Co-Chief Executive Officers of Strata.
How can I join the Strata conference call?
To join the live call, please register online to receive a dial-in number and unique PIN.
Where can I access the audio webcast of the call?
The audio-only webcast can be accessed from the Investors section of Strata's website or through the registration link.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$SRTA Insider Trading Activity
$SRTA insiders have traded $SRTA stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $SRTA stock by insiders over the last 6 months:
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$SRTA Revenue
$SRTA had revenues of $67.4M in Q1 2026. This is an increase of 24.08% from the same period in the prior year.
You can track SRTA financials on Quiver Quantitative's SRTA stock page.
You can access data on SRTA stock through the Quiver Quantitative API.
$SRTA Hedge Fund Activity
We have seen 56 institutional investors add shares of $SRTA stock to their portfolio, and 51 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$SRTA Price Targets
Multiple analysts have issued price targets for $SRTA recently. We have seen 2 analysts offer price targets for $SRTA in the last 6 months, with a median target of $8.0.
Here are some recent targets:
Full Release
NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Strata Critical Medical. (Nasdaq: SRTA, “Strata” or the “Company”), will release financial results for the second quarter ended June 30, 2026 on Tuesday, August 4, 2026 before the market opens. The company will hold a conference call on the same day at 8:00 am Eastern Time to discuss the results. The call will be hosted by Melissa Tomkiel, Strata’s Co-Chief Executive Officer and General Counsel, and Will Heyburn, Strata’s Co-Chief Executive Officer and Chief Financial Officer, and will include a question-and-answer session for call participants.
To join the live call, please register here . Upon registration, a dial-in and unique PIN will be provided to join the call.
An audio-only webcast of the call may be accessed from the Investors section of the Company’s website at https://ir.stratacritical.com/ or by registering at the link here . A replay of the webcast will be available for one year.
About Strata Critical Medical, Inc.
Strata is a time-critical logistics and medical services provider to the U.S. healthcare industry. We operate one of the nation’s largest air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated “one call” solution for donor organ recovery.
Strata’s core services include air and ground logistics, surgical organ recovery, organ placement and normothermic regional perfusion for the transplant industry, as well as perfusion staffing and equipment solutions for cardiovascular surgery centers, offered under the Trinity Medical Solutions and Keystone Perfusion brands.
For more information, visit www.srta.com .
Contacts
Mathew Schneider
investors@srta.com
Read full article here »